$117 Million is the total value of Birchview Capital, LP's 52 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
QDEL | QUIDELORTHO CORP | $4,762,427 | -11.9% | 65,203 | 0.0% | 4.05% | +0.1% | |
OVV | OVINTIV INC | $4,005,394 | +25.0% | 84,200 | 0.0% | 3.41% | +41.9% | |
IMGN | IMMUNOGEN INC | $3,015,300 | -15.9% | 190,000 | 0.0% | 2.57% | -4.5% | |
AZYO | ELUTIA INC | $2,366,913 | -39.4% | 1,655,184 | 0.0% | 2.01% | -31.2% | |
HROW | HARROW HEALTH INC | $2,155,500 | -24.5% | 150,000 | 0.0% | 1.84% | -14.3% | |
PHR | PHREESIA INC | $1,544,836 | -39.8% | 82,700 | 0.0% | 1.32% | -31.6% | |
ALKS | ALKERMES PLC | $1,400,500 | -10.5% | 50,000 | 0.0% | 1.19% | +1.6% | |
CORT | CORCEPT THERAPEUTICS INC | $1,362,250 | +22.4% | 50,000 | 0.0% | 1.16% | +39.0% | |
MASI | MASIMO CORP | $1,339,750 | -46.7% | 15,280 | 0.0% | 1.14% | -39.5% | |
FHTX | FOGHORN THERAPEUTICS INC | $1,324,215 | -29.0% | 264,843 | 0.0% | 1.13% | -19.4% | |
INBX | INHIBRX INC | $1,292,721 | -29.3% | 70,448 | 0.0% | 1.10% | -19.8% | |
ETRN | EQUITRANS MIDSTREAM CORPORATIO | $1,246,679 | -2.0% | 133,050 | 0.0% | 1.06% | +11.3% | |
ATEC | ALPHATEC HOLDINGS INC | $1,037,600 | -27.9% | 80,000 | 0.0% | 0.88% | -18.1% | |
VENTYX BIOSCIENCES INC | $916,872 | +5.9% | 26,400 | 0.0% | 0.78% | +20.2% | ||
PXD | PIONEER NATURAL RESOURCES CO | $872,290 | +10.8% | 3,800 | 0.0% | 0.74% | +25.8% | |
CYTK | CYTOKINETICS INC | $736,500 | -9.7% | 25,000 | 0.0% | 0.63% | +2.6% | |
PTGX | PROTAGONIST THERAPEUTICS INC | $633,840 | -39.6% | 38,000 | 0.0% | 0.54% | -31.5% | |
KNSA | KINIKSA PHARMACEUTICALS LTD | $521,100 | +23.4% | 30,000 | 0.0% | 0.44% | +40.1% | |
KALV | KALVISTA PHARMACEUTICALS INC | $385,200 | +7.0% | 40,000 | 0.0% | 0.33% | +21.5% | |
HALO | HALOZYME THERAPEUTICS INC | $382,000 | +5.9% | 10,000 | 0.0% | 0.32% | +20.4% | |
XENE | XENON PHARMACEUTICALS INC | $341,600 | -11.3% | 10,000 | 0.0% | 0.29% | +0.7% | |
FOLD | AMICUS THERAPEUTICS INC | $340,480 | -3.2% | 28,000 | 0.0% | 0.29% | +9.8% | |
STOK | STOKE THERAPEUTICS INC | $334,900 | -62.9% | 85,000 | 0.0% | 0.28% | -57.9% | |
SRPT | SAREPTA THERAPEUTICS INC | $303,050 | +5.9% | 2,500 | 0.0% | 0.26% | +20.0% | |
ARVN | ARVINAS INC | $294,600 | -20.9% | 15,000 | 0.0% | 0.25% | -10.0% | |
XNCR | XENCOR INC | $247,845 | -19.3% | 12,300 | 0.0% | 0.21% | -8.3% | |
2SEVENTY BIO INC | $234,545 | -61.3% | 59,833 | 0.0% | 0.20% | -55.9% | ||
CGEM | CULLINAN ONCOLOGY INC | $227,282 | -15.9% | 25,114 | 0.0% | 0.19% | -4.9% | |
KROS | KEROS THERAPEUTICS INC | $223,160 | -20.7% | 7,000 | 0.0% | 0.19% | -10.0% | |
IFRX | INFLARX NV | $149,000 | -33.2% | 50,000 | 0.0% | 0.13% | -24.0% | |
BCRX | BIOCRYST PHARMACEUTICALS INC | $141,600 | +0.6% | 20,000 | 0.0% | 0.12% | +14.2% | |
NKTR | NEKTAR THERAPEUTICS | $16,677 | +3.5% | 28,000 | 0.0% | 0.01% | +16.7% | |
YTEN | YIELD10 BIOSCIENCE INC | $6,126 | -85.3% | 18,750 | 0.0% | 0.01% | -83.9% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
ACCELERATE DIAGNOSTICS INC | 36 | Q3 2023 | 34.6% |
QUIDELORTHO CORP | 36 | Q3 2023 | 8.6% |
MASIMO CORP | 36 | Q3 2023 | 2.2% |
PIONEER NATURAL RESOURCES CO (PXD) | 36 | Q3 2023 | 0.7% |
XENCOR INC | 35 | Q3 2023 | 0.4% |
NEUROCRINE BIOSCIENCES INC | 33 | Q3 2023 | 7.4% |
CORCEPT THERAPEUTICS INC | 32 | Q3 2023 | 1.2% |
BIOGEN INC | 31 | Q2 2022 | 3.1% |
CONTRAFECT CORP | 30 | Q3 2022 | 1.6% |
YIELD10 BIOSCIENCE INC | 26 | Q3 2023 | 0.6% |
View Birchview Capital, LP's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
SOLENO THERAPEUTICS INC | March 19, 2019 | 742,635 | 2.3% |
YIELD10 BIOSCIENCE, INC. | December 29, 2017 | 186,079 | 2.2% |
HANSEN MEDICAL INC | February 16, 2016 | ? | ? |
METABOLIX, INC. | June 23, 2015 | 749,696 | 2.8% |
View Birchview Capital, LP's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
3/A | 2024-02-20 |
4/A | 2024-02-20 |
SC 13G/A | 2024-02-20 |
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-08 |
13F-HR | 2023-05-12 |
SC 13G/A | 2023-04-07 |
4 | 2023-03-27 |
3 | 2023-02-13 |
View Birchview Capital, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.